Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 1/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.37 |
| ▸ | TSHR | P16473 | 3/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | GFER | P55789 | 2/20 | 0.37 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23222166 | 0.91 | SLC2A1 (0.48) | SLC2A1SLC6A4ALDH1A1MAPTROCK1 | |
| SCHEMBL9439909 | 0.87 | SLC2A1 (0.53) | SLC2A1SLC6A4TDP1TSHRALDH1A1 | |
| SCHEMBL19559157 | 0.86 | SLC2A1 (0.43) | SLC2A1SLC6A4ALDH1A1L3MBTL1ROCK1 | |
| SCHEMBL9439771 | 0.85 | SLC2A1 (0.60) | SLC2A1SLC6A4TSHRALDH1A1CYP3A4 | |
| SCHEMBL20697728 | 0.84 | SLC2A1 (0.63) | SLC2A1ALDH1A1CYP3A4MAPTCYP1A2 | |
| SCHEMBL9043076 | 0.84 | SLC2A1 (0.63) | SLC2A1ALDH1A1CYP3A4MAPTCYP1A2 | |
| SCHEMBL6542887 | 0.82 | SLC2A1 (0.43) | SLC2A1SLC6A4TDP1SLC6A3MAPT | |
| SCHEMBL12056799 | 0.82 | SLC2A1 (0.43) | SLC2A1SLC6A4TDP1SLC6A3MAPT | |
| SCHEMBL29172465 | 0.82 | SLC2A1 (0.43) | SLC2A1SLC6A4TDP1SLC6A3MAPT | |
| SCHEMBL28572891 | 0.81 | HRH1 (0.41) | SLC2A1SLC6A4TDP1TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10280181-B2 | Coloring composition, anisotropic light absorption film, laminate, polarizing plate, image display device and compound | FUJIFILM CORPORATION (JP) | 2019-05-07 | — | — | US | disclosed |
| CN-1359390-B | factor VIIa inhibitors | AVENTIS PHARMA GMBH | 2010-05-26 | — | — | CN | disclosed |
| EP-1189929-B1 | FACTOR VIIA INHIBITORS | AVENTIS PHARMA GMBH (DE) | 2003-08-06 | — | — | EP | disclosed |
| US-6500803-B1 | Factor VIIa inhibitors | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2002-12-31 | — | — | US | disclosed |
| CN-1359390-A | factor VIIa inhibitors | AVENTIS PHARMA GMBH (DE) | 2002-07-17 | — | — | CN | disclosed |
| EP-1189929-A2 | FACTOR VIIA INHIBITORS | Aventis Pharma Deutschland GmbH (DE) | 2002-03-27 | — | — | EP | disclosed |
| WO-2000075172-A2 | FACTOR VIIa INHIBITORS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2000-12-14 | — | — | WO | disclosed |
| EP-1059302-A1 | Factor VIIa inhibitors | Aventis Pharma Deutschland GmbH (DE) | 2000-12-13 | — | — | EP | disclosed |
| US-5336749-A | Alicyclic diamines, alicyclic diisocyanates and polyisocyanato-isocyanurates and method for the preparation thereof | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1994-08-09 | — | — | US | disclosed |
| EP-0394058-B1 | ALICYCLIC DIAMINES, ALICYCLIC DIISOCYANATES AND POLYISOCYANATO-ISOCYANURATES AND METHOD FOR THE PREPARATION THEREOF | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1993-08-25 | — | — | EP | disclosed |
| US-5210286-A | Hydrogenation of corresponding aromatic compound, reaction with phosgene | MITSUI TOATSU CHEMICALS, INC. (JP) | 1993-05-11 | — | — | US | disclosed |
| US-5126426-A | Catalytic hydrogenation of aromatic diamine | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1992-06-30 | — | — | US | disclosed |
| CN-1046522-A | Alicyclic diamine and vulcabond of alicyclic ring and polyisocyanate root close isocyanuric acid ester and preparation method thereof | MITSUI TOATSU CHEMICALS (JP) | 1990-10-31 | — | — | CN | disclosed |
| EP-0394058-A1 | Alicyclic diamines, alicyclic diisocyanates and polyisocyanato-isocyanurates and method for the preparation thereof | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1990-10-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10280181-B2 | Coloring composition, anisotropic light absorption film, laminate, polarizing plate, image display device and compound | AHR, CTNNA1, HTR1D | SLC2A1 1500/4885SLC6A4 371/4885TDP1 3623/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.